RecruitingNot ApplicableNCT05574868

Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)

Evaluation of the Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis for the Treatment of Patients With Erectile Dysfunction


Sponsor

Rigicon, Inc.

Enrollment

182 participants

Start Date

Jan 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study evaluates the long-term safety and efficacy of the use of the Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis in patients with erectile dysfunction. This study follows patients implanted with the Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis for up to 3 years after implantation. This study will take approximately 6 months to enroll all subjects. (14 days, 6 weeks, 6 months, 12 months,18 months, 24 months, and 36 months, post-procedure. ) Subjects will be followed per protocol and institutional standard of care for ED and comorbidities.


Eligibility

Sex: MALEMin Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis for people with erectile dysfunction. The study is currently recruiting participants at 7 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERigicon Infla 10® Three-Piece Inflatable Penile Prosthesis

Treatment: Erectile dysfunction


Locations(7)

Wesley Hospital

Auchenflower, Australia

Canberra Laparoscopic, Robotic & Laser Urology Centre

Garran, Australia

Katelaris Urology

Hornsby, Australia

St George Urology

Hurstville, Australia

Advanced Urology Melbourne

Malvern, Australia

Shire Urology

Miranda, Australia

Urology South at Holmesglen Private Hospital

Moorabbin, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05574868


Related Trials